Initiation of highly active antiretroviral therapy among pregnant women in Cape Town, South Africa

Objective  To investigate highly active antiretroviral therapy (HAART) initiation among pregnant women and the optimum model of service delivery for integrating HAART services into antenatal care.

[1]  J. Currier,et al.  Effects of Highly Active Antiretroviral Therapy Duration and Regimen on Risk for Mother-to-Child Transmission of HIV in Johannesburg, South Africa , 2010, Journal of acquired immune deficiency syndromes.

[2]  L. Myer,et al.  Initiation of antiretroviral therapy among pregnant women in resource-limited countries: CD4+ cell count response and program retention , 2010, AIDS.

[3]  J. Stringer,et al.  Antiretroviral therapy in antenatal care to increase treatment initiation in HIV-infected pregnant women: a stepped-wedge evaluation , 2010, AIDS.

[4]  J. McIntyre.  Use of antiretrovirals during pregnancy and breastfeeding in low-income and middle-income countries , 2010, Current opinion in HIV and AIDS.

[5]  S. Cole,et al.  Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy. , 2009, The Journal of infectious diseases.

[6]  A D Harries,et al.  Task shifting in HIV/AIDS: opportunities, challenges and proposed actions for sub-Saharan Africa. , 2009, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[7]  S Downe,et al.  ‘Weighing up and balancing out’: a meta‐synthesis of barriers to antenatal care for marginalised women in high‐income countries , 2009, BJOG : an international journal of obstetrics and gynaecology.

[8]  M. Visser,et al.  Factors affecting disclosure in South African HIV-positive pregnant women. , 2008, AIDS patient care and STDs.

[9]  Karen Cohen,et al.  Antiretroviral therapy and early mortality in South Africa. , 2008, Bulletin of the World Health Organization.

[10]  L. Bekker,et al.  First large, multicenter, open-label study utilizing HLA-B*5701 screening for abacavir hypersensitivity in North America , 2008, AIDS.

[11]  F. Abdullah,et al.  A review of the prevention of mother-to-child transmission programme of the Western Cape provincial government, 2003 - 2004. , 2008, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[12]  T. Jones.  Psychosocial Dimensions of HIV Infection in Pregnancy , 2008, Clinical obstetrics and gynecology.

[13]  P. Simkhada,et al.  Factors affecting the utilization of antenatal care in developing countries: systematic review of the literature. , 2008, Journal of advanced nursing.

[14]  Lorraine B. Sanders.  Women's Voices: The Lived Experience of Pregnancy and Motherhood After Diagnosis With HIV , 2008, The Journal of the Association of Nurses in AIDS Care : JANAC.

[15]  W. El-Sadr,et al.  Scale-up of HIV care and treatment: can it transform healthcare services in resource-limited settings? , 2007, AIDS.

[16]  N. Shaffer,et al.  Approaches for scaling up human immunodeficiency virus testing and counseling in prevention of mother-to-child human immunodeficiency virus transmission settings in resource-limited countries. , 2007, American journal of obstetrics and gynecology.

[17]  L. Myer,et al.  Prevention of mother-to-child transmission services as a gateway to family-based human immunodeficiency virus care and treatment in resource-limited settings: rationale and international experiences. , 2007, American journal of obstetrics and gynecology.

[18]  Debra Jackson,et al.  Community-based situation analysis of maternal and neonatal care in South Africa to explore factors that impact utilization of maternal health services. , 2007, Journal of midwifery & women's health.

[19]  M. Cortina-Borja,et al.  Time to undetectable viral load after highly active antiretroviral therapy initiation among HIV-infected pregnant women. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  Lucy Gilson,et al.  Health Systems and Access to Antiretroviral Drugs for HIV in Southern Africa: Service Delivery and Human Resources Challenges , 2006, Reproductive health matters.

[21]  C. Garcia-Moreno,et al.  Rates, barriers and outcomes of HIV serostatus disclosure among women in developing countries: implications for prevention of mother-to-child transmission programmes. , 2004, Bulletin of the World Health Organization.

[22]  W. Blattner,et al.  Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. , 2002 .

[23]  L. Mofenson,et al.  Combination Antiretroviral Strategies for the Treatment of Pregnant HIV‐1‐Infected Women and Prevention of Perinatal HIV‐1 Transmission , 2002, Journal of acquired immune deficiency syndromes.

[24]  J. Myers,et al.  Public health lessons from a pilot programme to reduce mother-to-child transmission of HIV-1 in Khayelitsha. , 2001, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[25]  Gibson Bh,et al.  Ingestion of a laryngoscope light bulb during tracheal intubation. , 1992 .

[26]  V. C. Ha,et al.  The Peninsula Maternity and Neonatal Service. An urban community perinatal programme. , 1982 .

[27]  Black,et al.  Impact of antiretroviral therapy regimen and duration of therapy on risk of mother-to-child HIV transmission in Johannesburg, South Africa , 2009 .

[28]  B. Chi,et al.  Monitoring effectiveness of programmes to prevent mother-to-child HIV transmission in lower-income countries. , 2008, Bulletin of the World Health Organization.

[29]  J. Regan,et al.  Provision of a community perinatal service in a developing country. , 1994, The Australian & New Zealand journal of obstetrics & gynaecology.

[30]  R. Howland,et al.  The Peninsula Maternity and Neonatal Service. An urban community perinatal programme. , 1982, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.